Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Sialylation and fucosylation modulate inflammasome-activating eIF2 Signaling and microbial translocation during HIV infection.

Giron LB, Tanes CE, Schleimann MH, Engen PA, Mattei LM, Anzurez A, Damra M, Zhang H, Bittinger K, Bushman F, Kossenkov A, Denton PW, Tateno H, Keshavarzian A, Landay AL, Abdel-Mohsen M.

Mucosal Immunol. 2020 Mar 9. doi: 10.1038/s41385-020-0279-5. [Epub ahead of print]

PMID:
32152415
2.

Nicotinamide activates latent HIV-1 ex vivo in ART suppressed individuals, revealing higher potency than the association of two methyltransferase inhibitors, chaetocin and BIX01294.

Samer S, Arif MS, Giron LB, Zukurov JPL, Hunter J, Santillo BT, Namiyama G, Galinskas J, Komninakis SV, Oshiro TM, Sucupira MC, Janini LM, Diaz RS.

Braz J Infect Dis. 2020 Feb 24. pii: S1413-8670(20)30019-2. doi: 10.1016/j.bjid.2020.01.005. [Epub ahead of print]

3.

Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint.

Giron LB, Papasavvas E, Azzoni L, Yin X, Anzurez A, Damra M, Mounzer K, Kostman JR, Sanne I, Firnhaber CS, Tateno H, Liu Q, Montaner LJ, Abdel-Mohsen M.

AIDS. 2020 Apr 1;34(5):681-686. doi: 10.1097/QAD.0000000000002476.

PMID:
31972605
4.

HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country.

Nutini MFR, Hunter J, Giron L, Pires AFNPC, Kohiyama IM, Camargo M, Sucupira MCA, Benzaken AS, Ferreira PA, Truong HM, Diaz RS.

PLoS One. 2020 Jan 6;15(1):e0227082. doi: 10.1371/journal.pone.0227082. eCollection 2020.

5.

Glycosylation of Zika Virus is Important in Host-Virus Interaction and Pathogenic Potential.

Routhu NK, Lehoux SD, Rouse EA, Bidokhti MRM, Giron LB, Anzurez A, Reid SP, Abdel-Mohsen M, Cummings RD, Byrareddy SN.

Int J Mol Sci. 2019 Oct 21;20(20). pii: E5206. doi: 10.3390/ijms20205206.

6.

Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial.

Diaz RS, Shytaj IL, Giron LB, Obermaier B, Della Libera E Jr, Galinskas J, Dias D, Hunter J, Janini M, Gosuen G, Ferreira PA, Sucupira MC, Maricato J, Fackler O, Lusic M, Savarino A; SPARC Working Group.

Int J Antimicrob Agents. 2019 Nov;54(5):592-600. doi: 10.1016/j.ijantimicag.2019.08.001. Epub 2019 Aug 5.

PMID:
31394172
7.

TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes.

Schleimann MH, Kobberø ML, Vibholm LK, Kjær K, Giron LB, Busman-Sahay K, Chan CN, Nekorchuk M, Schmidt M, Wittig B, Damsgaard TE, Ahlburg P, Hellfritzsch MB, Zuwala K, Rothemejer FH, Olesen R, Schommers P, Klein F, Dweep H, Kossenkov A, Nyengaard JR, Estes JD, Abdel-Mohsen M, Østergaard L, Tolstrup M, Søgaard OS, Denton PW.

EBioMedicine. 2019 Jul;45:328-340. doi: 10.1016/j.ebiom.2019.07.005. Epub 2019 Jul 9.

8.

Laboratory surrogate markers of residual HIV replication among distinct groups of individuals under antiretroviral therapy.

Giron LB, Tenore SB, Janini LMR, Sucupira MCA, Diaz RS.

PLoS One. 2019 Jun 17;14(6):e0217502. doi: 10.1371/journal.pone.0217502. eCollection 2019.

9.

Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling.

Colomb F, Giron LB, Premeaux TA, Mitchell BI, Niki T, Papasavvas E, Montaner LJ, Ndhlovu LC, Abdel-Mohsen M.

Front Immunol. 2019 Feb 20;10:267. doi: 10.3389/fimmu.2019.00267. eCollection 2019.

10.

Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis.

Colomb F, Giron LB, Trbojevic-Akmacic I, Lauc G, Abdel-Mohsen M.

Curr HIV/AIDS Rep. 2019 Apr;16(2):151-168. doi: 10.1007/s11904-019-00433-w. Review.

PMID:
30707400
11.

CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.

Abdel-Mohsen M, Kuri-Cervantes L, Grau-Exposito J, Spivak AM, Nell RA, Tomescu C, Vadrevu SK, Giron LB, Serra-Peinado C, Genescà M, Castellví J, Wu G, Del Rio Estrada PM, González-Navarro M, Lynn K, King CT, Vemula S, Cox K, Wan Y, Li Q, Mounzer K, Kostman J, Frank I, Paiardini M, Hazuda D, Reyes-Terán G, Richman D, Howell B, Tebas P, Martinez-Picado J, Planelles V, Buzon MJ, Betts MR, Montaner LJ.

Sci Transl Med. 2018 Apr 18;10(437). pii: eaar6759. doi: 10.1126/scitranslmed.aar6759.

12.

Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy.

Vadrevu SK, Trbojevic-Akmacic I, Kossenkov AV, Colomb F, Giron LB, Anzurez A, Lynn K, Mounzer K, Landay AL, Kaplan RC, Papasavvas E, Montaner LJ, Lauc G, Abdel-Mohsen M.

J Leukoc Biol. 2018 Sep;104(3):461-471. doi: 10.1002/JLB.3HI1217-500R. Epub 2018 Apr 6.

13.

Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy.

Bangirana P, Ruel TD, Boivin MJ, Pillai SK, Giron LB, Sikorskii A, Banik A, Achan J.

J Int AIDS Soc. 2017 Oct;20(2). doi: 10.1002/jia2.25015.

14.

Thalidomide is Associated With Increased T Cell Activation and Inflammation in Antiretroviral-naive HIV-infected Individuals in a Randomised Clinical Trial of Efficacy and Safety.

Vergara TRC, Samer S, Santos-Oliveira JR, Giron LB, Arif MS, Silva-Freitas ML, Cherman LA, Treitsman MS, Chebabo A, Sucupira MCA, Da-Cruz AM, Diaz RS; SPARC Working Group.

EBioMedicine. 2017 Sep;23:59-67. doi: 10.1016/j.ebiom.2017.08.007. Epub 2017 Aug 12.

15.

High prevalence and incidence of HIV-1 in a counseling and testing center in the city of Itajaí, Brazil.

Grinberg G, Giron LB, Knoll RK, Galinskas J, Camargo M, Arif MS, Samer S, Janini LM, Sucupira MC, Diaz RS.

Braz J Infect Dis. 2015 Nov-Dec;19(6):631-5. doi: 10.1016/j.bjid.2015.08.001. Epub 2015 Sep 9.

16.

Human gammaherpesviruses viraemia in HIV infected patients.

Ferraz da Silva AP, Giron LB, Ramos da Silva S, Naime Barbosa A, Almeida RA, Elgui de Oliveira D.

J Clin Pathol. 2015 Sep;68(9):726-32. doi: 10.1136/jclinpath-2014-202840. Epub 2015 May 15.

PMID:
25979989
17.

In vivo HIV-1 hypermutation and viral loads among antiretroviral-naive Brazilian patients.

de Lima-Stein ML, Alkmim WT, Bizinoto MC, Lopez LF, Burattini MN, Maricato JT, Giron L, Sucupira MC, Diaz RS, Janini LM.

AIDS Res Hum Retroviruses. 2014 Sep;30(9):867-80. doi: 10.1089/AID.2013.0241. Epub 2014 Aug 25.

18.

Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus.

Giron LB, Ramos da Silva S, Barbosa AN, Monteiro de Barros Almeida RA, Rosário de Souza Ld, Elgui de Oliveira D.

J Med Virol. 2013 Dec;85(12):2110-8. doi: 10.1002/jmv.23722. Epub 2013 Sep 6.

PMID:
24014234
19.

Comparative effectiveness of dried-plasma hepatitis B virus viral load (VL) testing in three different VL commercial platforms using ViveST for sample collection.

Zanoni M, Giron LB, Vilhena C, Sucupira MC, Lloyd RM Jr, Diaz RS.

J Clin Microbiol. 2012 Jan;50(1):145-7. doi: 10.1128/JCM.01016-11. Epub 2011 Oct 19.

Supplemental Content

Loading ...
Support Center